Skip to main content
logo
Idorsia Ltd (SWX:IDIA)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
4.584
+0.310 (7.25%)
May 13, 2026, 5:31 PM CET

Idorsia Revenue

In the year 2025, Idorsia had annual revenue of 220.58M CHF with 96.06% growth. Idorsia had revenue of 47.97M in the quarter ending December 31, 2025, a decrease of -19.91%.

Revenue
220.58M
Revenue Growth
+96.06%
P/S Ratio
5.30
Revenue / Employee
483.74K
Employees
487
Market Cap
1.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025220.58M108.08M96.06%
Dec 31, 2024112.51M-39.88M-26.17%
Dec 31, 2023152.39M55.28M56.93%
Dec 31, 202297.10M61.75M174.70%
Dec 31, 202135.35M-36.41M-50.74%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bachem Holding AG695.07M
Basilea Pharmaceutica AG232.38M
Santhera Pharmaceuticals Holding AG77.19M
Newron Pharmaceuticals17.81M
BioVersys AG3.18M
Molecular Partners AG681.00K
Xlife Sciences AG275.31K
Addex Therapeutics173.00K
Revenue Rankings

Idorsia News

More News